These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9875573)

  • 1. Lest we forget: neuropsychiatry and the new generation anti-HIV drugs.
    Gonzalez A; Everall IP
    AIDS; 1998 Dec; 12(18):2365-7. PubMed ID: 9875573
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine.
    Fisac C; Fumero E; Crespo M; Roson B; Ferrer E; Virgili N; Ribera E; Gatell JM; Podzamczer D
    AIDS; 2005 Jun; 19(9):917-25. PubMed ID: 15905672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurologic and psychiatric complications of antiretroviral agents.
    Treisman GJ; Kaplin AI
    AIDS; 2002 Jun; 16(9):1201-15. PubMed ID: 12045485
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Gonzalez and Everall: Lest we forget: neuropsychiatry and the new generation anti-HIV drugs.
    Colebunders R; Verdonck K
    AIDS; 1999 May; 13(7):869. PubMed ID: 10357394
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply. Lest we forget: neuropsychiatry and the new generation anti-HIV drugs.
    Gonzalez A; Everall I
    AIDS; 1999 Oct; 13(14):1996. PubMed ID: 10513671
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuropsychiatric reaction induced by abacavir.
    Colebunders R; Hilbrands R; De Roo A; Pelgrom J
    Am J Med; 2002 Nov; 113(7):616. PubMed ID: 12459415
    [No Abstract]   [Full Text] [Related]  

  • 7. NNRTI hepatotoxicity: efavirenz versus nevirapine.
    Pulido F; Torralba M
    J HIV Ther; 2002 Nov; 7 Suppl 2():S3-16. PubMed ID: 12735215
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-HIV drugs].
    Raffi F
    Rev Prat; 1999 Oct; 49(16):1763-71. PubMed ID: 10578607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical implications of antiretroviral pharmacogenomics.
    Fox J; Boffito M; Winston A
    Pharmacogenomics; 2006 Jun; 7(4):587-96. PubMed ID: 16753006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of pharmacokinetic interaction between nelfinavir and nevirapine.
    Skowron G; Leoung G; Kerr B; Dusek A; Anderson R; Beebe S; Grosso R
    AIDS; 1998 Jul; 12(10):1243-4. PubMed ID: 9677174
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of etravirine in combination antiretroviral therapy].
    Domingo P
    Enferm Infecc Microbiol Clin; 2009 Dec; 27 Suppl 2():46-51. PubMed ID: 20116628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of drug-resistant HIV-1 genotypes in heavily pre-treated patients on current virological failure.
    Briones C; Soriano V; González-Lahoz J
    AIDS; 2000 Jul; 14(11):1659-60. PubMed ID: 10983655
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiretroviral-induced toxiderma in HIV-infected patients].
    Caumes E; Bossi P; Katlama C; Bricaire F
    Presse Med; 2003 Sep; 32(28):1325-33. PubMed ID: 14506444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipodystrophy associated with nevirapine-containing antiretroviral therapies.
    Aldeen T; Wells C; Hay P; Davidson F; Lau R
    AIDS; 1999 May; 13(7):865-7. PubMed ID: 10357391
    [No Abstract]   [Full Text] [Related]  

  • 15. Understanding the reverse transcriptase inhibitors in HIV.
    Edmonds-Ogbuokiri J
    Fac Notes (New Orleans La); 1998; 10(6):13-5. PubMed ID: 11366142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nevirapine-induced neuropsychiatric complications, a class effect of non-nucleoside reverse transcriptase inhibitors?
    Morlese JF; Qazi NA; Gazzard BG; Nelson MR
    AIDS; 2002 Sep; 16(13):1840-1. PubMed ID: 12218402
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions among drugs for HIV and opportunistic infections.
    Piscitelli SC; Gallicano KD
    N Engl J Med; 2001 Mar; 344(13):984-96. PubMed ID: 11274626
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel approaches for the treatment of HIV.
    Arroyo HT
    Newsline People AIDS Coalit N Y; 1998 Mar; ():16-7. PubMed ID: 11367450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-nucleoside reverse transcriptase inhibitors (NNRTIs)-induced Stevens-Johnson syndrome and gynecomastia in an HIV-infected child: A case report.
    Saka B; Akakpo AS; Bassowa A; Dapam AN; Mahamadou G; Teclessou JN; Mouhari-Toure A; Laouali AY; Mensah E; Kombaté K; Pitché P
    Ann Dermatol Venereol; 2018 Dec; 145(12):773-776. PubMed ID: 30301570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone withdrawal when starting an antiretroviral regimen including nevirapine.
    Heelon MW; Meade LB
    Pharmacotherapy; 1999 Apr; 19(4):471-2. PubMed ID: 10212021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.